Ad
BIO Quote Trading Chart Bio-Rad Laboratories Inc. Class A
$510.20 Last:
-7.24% Change Percent:
$518.87 Open:
$550 Previous Close:
$524.09 High:
$509.21 Low:
109,803 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BIO Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-19 | 518.87 | 550 | 524.09 | 509.21 | 109,803 |
| 2022-08-18 | 525.04 | 550 | 527.34 | 515.45 | 94,544 |
| 2022-08-17 | 529.78 | 550 | 541.15 | 521.39 | 96,415 |
| 2022-08-16 | 537.88 | 550 | 542.2833 | 531.87 | 74,809 |
| 2022-08-15 | 547 | 550 | 552.46 | 541.97 | 169,074 |
| 2022-08-12 | 553.89 | 550 | 556.32 | 542.32 | 79,713 |
| 2022-08-11 | 552.49 | 550 | 572.7 | 546.13 | 132,218 |
| 2022-08-10 | 529.25 | 550 | 549.66 | 528.995 | 171,569 |
| 2022-08-09 | 533 | 550 | 533 | 516.28 | 104,974 |
| 2022-08-08 | 539.17 | 550 | 544.8818 | 534.5 | 105,934 |
| 2022-08-05 | 531.92 | 550 | 540.9 | 528.77 | 84,864 |
| 2022-08-04 | 548.57 | 550 | 550.18 | 534.61 | 100,902 |
| 2022-08-03 | 552.14 | 550 | 559.03 | 547.92 | 142,879 |
| 2022-08-02 | 550.13 | 550 | 561.26 | 545.02 | 108,218 |
| 2022-08-01 | 558.45 | 550 | 564.5 | 552.59 | 170,811 |
| 2022-07-29 | 560.99 | 550 | 569.89 | 554.94 | 247,681 |
| 2022-07-28 | 550 | 550 | 563.78 | 542.98 | 236,276 |
| 2022-07-26 | 528.37 | 528.37 | 529.81 | 517.84 | 53,177 |
| 2022-07-19 | 482.83 | 490.09 | 491.6665 | 481.37 | 154,180 |
| 2022-07-18 | 494.93 | 475.79 | 500.42 | 472.7975 | 188,895 |
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE New...
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2022. Second-quarter 2022 net sales were $691.1 million, a decrease of 3.5 percent comp...
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the second quarter of 2022 on Thursday, July 28, 2022, following the close of the market. The company will discuss these resu...